EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment

Purvi Purohit, Parmod Kumar, Anupama Modi

Frontiers in Oncology · 10.06.2026 · 16

DOI: 10.3389/fonc.2026.1885867 ↗

Kurz gefasst

Korrektur in der Zeitschrift Frontiers in Oncology, online erschienen am 10.06.2026. Verfasst von Purvi Purohit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences Jodhpur, Jodhpur, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

TME (tumor microenvironment)breast cancerepigenomicsmetabolomicsprecision medicine

Autor:innen und Institutionen

  • Department of Biochemistry, All India Institute of Medical Sciences Jodhpur, Jodhpur, India.
  • Department of Medical Oncology Hematology, All India Institute of Medical Sciences Jodhpur, Jodhpur, India.
  • GTU-School of Applied Sciences and Technology, Ahmedabad, India.

Zitieren

APA

Purohit, P., Kumar, P., & Modi, A. (2026). Correction: Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1885867

Vancouver

Purohit P, Kumar P, Modi A. Correction: Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1885867

BibTeX
@article{Purohit2026,
  author = {Purohit, Purvi and Kumar, Parmod and Modi, Anupama},
  title = {Correction: Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1885867}
}
Kostenlos starten →